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Purpose: To analyze genotype-phenotype correlation in patients originating from Polish population with the transforming
growth factor beta induced (TGFBI) corneal dystrophies.
Methods: Sixty affected and 31 unaffected individuals from 15 unrelated Polish families were included in the study. The
clinical diagnosis was based on the slit-lamp exam, 1310 nm time domain and 1310 nm swept source spectral domain
optical coherence tomography (OCT). Histopathologic analysis was performed on 10 available corneal buttons. Exons of
the TGFBI gene were screened for mutations with polymerase chain reaction (PCR) and direct DNA sequencing.
Results: We found the lattice phenotype dominant compared to the granular one in the Polish population (41:16 patients;
lattice:granular). We identified five distinct mutations responsible for TGFBI corneal dystrophies (R124R, R124H,
R555W, R555Q, and H626R). There was a strong genotype-phenotype correlation in the case of R124R and R555W
mutations, while there was a distinct phenotypic heterogeneity in the case of the H626R mutation. OCT analysis revealed
that the reflectivity, location and pattern of the corneal deposits were different among the TGFBI corneal dystrophies. The
advantage of spectral swept source OCT over time-domain OCT scans is a more distinct visualization of the Bowman’s
layer area and deposits located under the epithelium.
Conclusions:  This  study  underlines  the  role  of  comprehensive  phenotype-genotype  analysis  in  TGFBI  corneal
dystrophies, describes for the first time the TGFBI mutation spectrum in a Polish population and reveals phenotypic
heterogeneity in the case of the H626R mutation.
Corneal dystrophies as a group of inherited, bilateral,
symmetric, slowly progressive corneal diseases without any
relationship to environmental or systemic factors have been
mapped to 10 different chromosomes: 1, 2, 5, 9, 10, 12, 16,
17, 20, and X [1]. Knowledge regarding the molecular basis
of corneal dystrophies is still evolving, as underlined in the
IC3D  classification  (the  International  Committee  for
Classification of Corneal Dystrophies).
Transforming  growth  factor-β  induced  gene  corneal
dystrophies (TGFBI; OMIM 601692) are a heterogeneous
group  of  dystrophies,  including  epithelial  basement
membrane  corneal  dystrophy  (EBMD;  OMIM  121820),
Bowman’s  layer  dystrophies:  Thiel-Behnke  corneal
dystrophy (TBCD; OMIM 602082), Reis-Bűcklers – granular
corneal dystrophy type III (GCD3; OMIM 608470), and the
stromal dystrophies: lattice corneal dystrophy type I (LCDI;
OMIM 122200) and variants (LCDvariants), granular corneal
dystrophy type I (GCDI, OMIM 121900) and II (granular-
lattice, Avellino – GCD2; OMIM 607541).
Correspondence  to:  Anna  K.  Nowińska,  Department  of
Ophthalmology,  District  Railway  Hospital,  ul.  Panewnicka  65;
40-760  Katowice,  Poland;  Phone:  +48502905488;  email:
atrum2@gmail.com
More than 50 distinct disease-causing mutations have
been identified in the TGFBI gene [2]. Different population-
wide studies revealed two mutational hot spots at codons R124
and R555 [3-5]. Researchers have established that TGFBI
corneal dystrophies are inherited with complete penetrance
and dominance and certain TGFBI mutations are correlated
with a specific phenotype. Researchers have also established
that the R124C mutation is associated with lattice corneal
dystrophy type I, the R124L mutation is associated with Reis-
Bucklers  corneal  dystrophy,  the  R555W  mutation  is
associated with granular corneal dystrophy type I, the R555Q
mutation is associated with Thiel-Behnke corneal dystrophy,
whereas granular corneal dystrophy type II is associated with
the R124H mutation. Later studies reported cases of increased
severity of deposits, multiple recurrences and earlier onset for
patients bearing homozygous mutations suggesting a semi-
dominant  inheritance  pattern  [6-11].  Cases  of  reduced
penetrance have also been reported [12,13]. Several reports
underlined  the  phenotypic  and  mutational  heterogeneity
according to rare mutations and, in recent years, to common
TGFBI mutations [14-20].
Although molecular studies in differential diagnosis of
TGFBI dystrophies have been used increasingly in clinical
practice  during  recent  years,  phenotype  analysis  and
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2333histopathologic examination remain the “gold standard” for
determining the type of corneal dystrophy. Additionally, in
recent years, corneal imaging techniques have been developed
that  allow  in  vivo  corneal  morphology  and  morphometry
assessment to analyze the disease progression and determine
the method of treatment. Confocal microscopy, invented in
1955 and developed in the nineties, has been used for high-
resolution imaging and provides en face images of the corneal
layers  [21].  The  IC3D  classification  system  contains  a
description  of  confocal  microscopy  images  of  all  corneal
dystrophies. Optical coherence tomography (OCT) is a high-
speed, high-resolution, non-contact optical imaging technique
introduced in 1991 for cross-sectional imaging in biologic
systems [22]. Anterior eye segment imaging with the 830 nm
light  wavelength  OCT  was  demonstrated  in  1994  [23].
Introduction of transscleral anterior eye segment imaging was
achieved by changing the light wavelength from 830 nm to
1310 nm [24]. In recent years, OCT technology has been
revolutionized  by  the  development  of  spectral  domain
technology, which provides an increased signal-to-noise ratio
and increased robustness compared with time domain OCT
[25]. OCT is proven to provide reliable anterior eye segment
parameters measurements characterized by good repeatability
and reproducibility [26].
We  report,  for  the  first  time,  the  TGFBI  mutation
spectrum and genotype-phenotype correlation integrating the
slit-lamp  exam,  corneal  morphology  assessment  with  two
OCT  systems,  histological  exam  and  genetic  analysis  of
patients encompassing a population in Poland.
METHODS
The  study  was  approved  by  the  Ethics  Committee  of  the
Medical  University  of  Silesia,  Katowice,  Poland  (SUM
NN-6501–175/I/07). All patients had to sign informed consent
forms before undergoing any study procedure. A family was
included in the study only if at least two family members had
been diagnosed with TGFBI corneal dystrophy.
Patients: Sixty affected and 31 unaffected individuals (50
women and 41 men) from 15 unrelated Polish families were
included in the study (family F1-F15). The mean age of the
patients  was  46  years  (±19  years).  The  mean  number  of
examined patients was 5 per family (ranging from 3 to 11
patients). Seventeen patients had undergone a keratoplasty
procedure in the past, while 9 patients underwent keratoplasty
while this study was performed.
Phenotype  analysis:  A  detailed  family  history  was
collected,  and  pedigree  charts  were  constructed  for  all
patients. We analyzed the age at onset of symptoms and type
of symptoms reported by patients. The clinical examination
consisted  of  visual  acuity,  slit-lamp  biomicroscopy  with
photography,  time  domain  and  spectral  domain  optical
coherence tomography.
We  analyzed  corneal  change  patterns,  location,
symmetry  and  progression  with  age.  In  addition,
heterogeneity of corneal morphology among patients with the
same TGFBI mutation was assessed.
Optical  coherence  tomography:  Anterior  segment
imaging  was  performed  by  one  observer.  We  used  two
anterior  segment  optical  coherence  systems:  time  domain
OCT (Visante OCT; Carl Zeiss Meditec, Inc., Dublin, CA)
and 1310 nm swept source spectral domain OCT (SS-1000
CASIA; Tomey Co., Nagoya, Japan). During the time domain
OCT  exam,  corneal  morphology  was  assessed  on  high-
resolution corneal quad scans (10×3 mm; 4×512 A-scans).
During  the  swept  source  spectral  OCT  exam,  corneal
morphology  was  assessed  with  radial  scans  (10×4  mm;
128×512 A-scans).
Histologic examination: The 10 available corneal buttons
from  9  patients  (6  without  the  Descemet  membrane  and
posterior  corneal  stroma  after  deep  anterior  lamellar
keratoplasty and 4 whole corneal buttons after penetrating
keratoplasty) were processed by standard methods involving
sectioning of the tissue samples. Corneal sections were stained
with hematoxylin and eosin (HE), periodic acid-Schiff (PAS),
Alcian blue, Masson's trichrome, and Congo red and further
analyzed with light microscopy for the presence of amyloid
and/or  hyaline  deposits.  The  presence  of  amyloids  was
confirmed  by  birefringence  when  viewed  under  polarized
light.
DNA collection, isolation, amplification and sequencing:
DNA  was  isolated  from  dry  blood  samples  collected  on
FTA® cards (Whatmann, Maidstone, UK). For DNA isolation,
a 2.0-mm-diameter disc was punched and collected into a
sterile Eppendorf tube. DNA was isolated by using the lysis
and  neutralization  solutions  from  REDExtract-N-Amp™
Blood PCR Kit (Sigma-Aldrich, St. Louis, MO) according to
the  manufacturer’s  protocol.  Exons  were  amplified  by
polymerase chain reaction (PCR) with the primers published
by Munier et al. [3] (Table 1). The PCR product was purified
and directly submitted for DNA sequencing. In case of 15
probands, we started the analysis with screening exon 4 and
exon 12 of the TGFBI gene, where hot spot sites for mutations
have  been  previously  reported  [2-5].  If  no  mutation  was
revealed, we screened TGFBI exon by exon until the mutation
was defined. After that, in case of other family members, we
analyzed the exons for which the mutation was defined for the
proband.
Direct  sequencing  was  performed  using  the  BigDye
Terminator  v3.1  (Applied  Biosystems;  Life  Technologies,
Foster  City,  CA).  A  3730xl  DNA  Analyzer  (Applied
Biosystems) was used to collect the sequence data. Nucleotide
sequences were compared with the published sequence of
TGFBI  (GenBank  NM_000358)  to  analyze  the  sequence
changes.
RESULTS
Clinical findings: Clinical examination revealed 8 families
(33 patients with clinical manifestation) with lattice corneal
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2334dystrophy type I (F1, F3, F5, F6, F12, F13, F14, and F15), 2
families (8 patients) with variants of lattice corneal dystrophy
(F2 and F7), 3 families (14 patients) with granular corneal
dystrophy type I (F4, F10, and F11), 1 family (2 patients) with
granular  corneal  dystrophy  type  II  (F9)  and  1  family  (3
patients) with Thiel-Behnke corneal dystrophy (F8).
The disease showed an autosomal dominant inheritance
pattern in all families as revealed by pedigree analysis. The
age of onset varied between different corneal dystrophies. In
the case of patients with TBCD, LCDI, and GCDI and II, the
onset of the disease was in the first and second decades of life.
In patients with LCD variants, the onset was delayed to the
fourth  and  fifth  decades  of  life.  Patients  from  all  studied
families  reported  recurrent  erosion  and  visual  impairment
during the course of the disease.
Molecular analysis: Sequencing of the TGFBI gene revealed
a nucleotide transition in all affected and none of unaffected
family members: c.1711G>A of exon 12 causing the R555Q
mutation in Thiel-Behnke corneal dystrophy (F8), c.1710C>T
of exon 12 causing the R555W mutation in granular corneal
dystrophy type 1 (F4, F10, and F11); c.418G>A of exon 4
causing the R124H mutation in granular corneal dystrophy
type 2 (F9), c.417C>T of exon 4 causing the R124C mutation
in lattice corneal dystrophy type 1 (F1, F3, F5, F6, F12, F13,
F14, and F15), and c.1924A>G of exon 14 causing the H626R
mutation in variant of lattice corneal dystrophy (F2 and F7).
Results  of  genetic  analysis  with  comparison  to  corneal
phenotypes are summarized in Table 2.
Optical coherence tomography: All corneal changes were
hyperreflective in the time domain and spectral OCT scans,
but  the  level  of  increased  reflectivity  was  different  for
different types of corneal dystrophies and increased in the
following  order:  lattice  corneal  dystrophy,  Thiel-Behnke
corneal  dystrophy,  granular  corneal  dystrophy  type  I  and
granular corneal dystrophy type II. The opacities also were
different in shape and pattern: from diffuse areas of increased
reflectivity in lattice corneal dystrophy type I to focal, distinct
and hyperreflective opacities in granular corneal dystrophies
type I and II (Figure 1B,C,E,F,H,I and Figure 2B,D,F).
When comparing images of time-domain and spectral
domain OCT, we noticed that all changes revealed on spectral
swept source OCT scans were also visible on time-domain
TABLE 1. TABLE SHOWING TGFBI PRIMER SEQUENCES.
Exon Sequence of forward and reverse primer Annealing temp (°C) Product size (bp)
1 5’-CCGCTCGCAGCTTACTTAAC-3’ 58 362
  5’-AGCGCTCCATGCTGCAAGGT-3’    
2 5’-GTGGACGTGCTGATCATCTT-3’ 55 170
  5’-TCCTGGCTGGTTACAGATAC-3’    
3 5’-GCTGTGGAGGCAACTTAGTG-3’ 55 280
  5’-GAGAATGCCATGTCCTTGTG-3’    
4 5’-CCCCAGAGGCCATCCCTCCT-3’ 58 226
  5’-CCGGGCAGACGGAGGTCATC-3’    
5 5’-TAAACACAGAGTCTGCAGCC-3’ 55 260
  5’-TTCATTATGCACCAAGGGCC-3’    
6 5’-TGTGTTGACTGCTCATCCTT-3’ 55 316
  5’-CATTCAGGGGAACCTGCTCT-3’    
7 5’-AAGTGTGCCAAGTTGACCTC-3’ 55 588
  5’-GGCAGGTGGTATGTTCATCT-3’    
8 5’-AGAAGGCGAGGAGGATCTGG-3’ 55 508
  5’-CAGTGGCCGAGAAGCTGTGA-3’    
9 5’-CATTCCTGCTGATGTGTGTCATGC-3’ 55 315
  5’-GGGTGCTGTAAATCGGAGAGTGTTG-3’    
10 5’-TCTGGACCTAACCATCACCC-3’ 55 206
  5’-CAGGAGCATGATTAGGACC-3’    
11 5’-CTCGTGGGAGTATAACCAGT-3’ 55 220
  5’-TGGGCAGAAGCTCCACCCGG-3’    
12 5’-CATTCCAGTGGCCTGGACTCTACTATC-3’ 58 340
  5’-GGGGCCCTGAGGGATCACTACTT-3’    
13 5’-CCTCCTTGACCAGGCTAATTAC-3’ 55 300
  5’-GGCTGCAACTTGAAGGTTGTG-3’    
14 5’-CTGTTCAGTAAACACTTGCT-3’ 55 265
  5’-CTCTCCACCAACTGCCACAT-3’    
15 5’-ACAGCATCTCACCTCAGTGT-3’ 55 360
  5’-AACCTAGCAGGCATCTTACC-3’    
16 5’-GCTTGCACAACTTATGTCTG-3’ 55 251
  5’-CAGGTCTGCAATGACTTC-3’    
17 5’-CCTGGTCCTTGAGATTCTGA-3’ 55 489
  5’-GAGGCTGGATTGCTTGATTC-3’    
               Based on data previously published by Munier et al. [3].
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2336Figure 1. Representative images of slit-lamp photographs, 1310 nm time-domain and 1310 nm swept source spectral domain optical coherence
tomography scans of patients with granular corneal dystrophy type I (family F4), granular corneal dystrophy type II (family F9), and Thiel-
Behnke corneal dystrophy (family F8). A: Female patient (F4; 53 years). Slit-lamp photograph showing gray-white granular deposits located
centrally, with clear intervening stroma. GCDI/ R555W mutation. B: Female patient (F4; 53 years). High-resolution corneal scan – 1310 nm
time. domain OCT. Focal granular hyperreflective changes located at different depths within the corneal stroma. GCDI/ R555W mutation.
C: Female patient (F4; 53 years). Radial scan-swept source 1310 nm spectral OCT. Focal granular hyperreflective changes located at different
depths within the corneal stroma. The Bowman’s layer area shows a distinct irregularity. GCDI/ R555W mutation. D: Female patient (F9; 44
years). Slit-lamp photograph. Centrally located, multiform: star- and disc-shaped opacities. No lattice lines are visible, either on direct light
nor on retroillumination. GCDII/ R124H mutation. E: Female patient (F9; 44 years). High-resolution corneal scan – 1310 nm time domain
OCT. Highly reflective opacities with distinct borders located in the anterior corneal part. GCDII/ R124H mutation. F: Female patient (F9;
44 years). Radial scan-swept source 1310 nm spectral OCT. Highly reflective disc-shaped changes located in the anterior stroma, under the
epithelium, involving Bowman’s layer. One hyperreflective granular opacity located deeper in the mid stroma. GCDII/ R124H mutation. G:
Female patient (F8; 38 years). Slit-lamp photograph. Diffuse corneal changes showing reticular, “honeycomb” pattern located in the anterior
corneal part. TBCD/ R555Q mutation. H: Female patient (F8; 38 years). High-resolution corneal scan – 1310 nm time domain OCT. The
diffuse boarder of increased reflectivity in the anterior part of the cornea (arrowheads). In the Bowman’s layer area, there is a distinct irregularity
due to corneal opacities (arrows). TBCD/ R555Q mutation. I: Female patient (F8; 38 years). Radial scan-swept source 1310 nm spectral OCT.
Bowman’s layer is replaced by an irregular pattern of opacities. TBCD/R555Q mutation.
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2337OCT. That makes both techniques useful for establishing the
phenotype features of each TGFBI corneal dystrophy and
monitoring the progression of the disease. The advantage of
spectral swept source OCT over time-domain OCT scans is
more distinct visualization of the Bowman’s layer area and
the  deposits  located  under  the  epithelium  (Figure
1B,C,E,F,H,I).
Phenotypic heterogeneity: Patients with TGFBI mutations
R124C and R555W were characterized by a homogenous
phenotype.  The  corneal  phenotype  of  patients  with  the
R555W  mutation  (families  F4,  F10,  and  F11)  was
characterized by granular crumb-like deposits in the central
cornea, with age becoming located deeper in the stroma. In
OCT scans, focal distinct opacities of increased reflectivity
corresponding to corneal deposits were visible (Figure 1A-C).
Two available corneal buttons revealed the interruption or
local  absence  of  Bowman’s  layer,  irregularity  of  the
epithelium in correspondence with the superficial granular
deposits and multiple granular deposits in the corneal stroma
(Figure 3C,D). The corneal phenotype of patients with the
R124C mutation (Families F1, F3, F5, F6, F12, F13, F14, and
F15) was characterized by fragile, multiple lattice lines in the
anterior to mid stroma in the central cornea with diffuse areas
of increased reflectivity on corresponding OCT scans (Figure
2A,B). Five available corneal buttons revealed deposits that
stained positive with Congo red. Green birefringence was
visible with a polarizing filter (Figure 3A). Accompanying
changes involved thinning of the epithelium and interruption
of Bowman’s layer.
In the case of patients with R124H and R555Q mutations,
we could not assess interfamilial heterogeneity, because there
was only 1 family of each type. The phenotype of the R555Q
mutation (family F8) was characterized by a “honeycomb”
pattern of corneal deposits in the anterior corneal part. The
changes visible on the OCT scans were limited to the anterior
corneal stroma and the area of Bowman’s layer (Figure 1G-
I). Since no members of family F8 underwent keratoplasty,
the corneal button for histologic analysis was not available.
The corneal changes in family F9 with the R124H mutation
involved granular-, star- and disc-shaped stromal opacities
without lattice lines. The opacities were highly reflective on
OCT  scans  (Figure  1D-F).  Histologic  analysis  revealed
multiple granular deposits stained positively with Masson
trichrome and a few sub Bowman’s layer Congo red positive
amyloid deposits (Figure 3E,F).
Patients with the H626R mutation (Families F2 and F7)
revealed interfamilial heterogeneity (Figure 2C-F). Corneal
changes were asymmetric in both families. On the slit-lamp
Figure 2. Representative images of slit-lamp photographs and 1310 nm time-domain optical coherence tomography scans of patients with
lattice corneal dystrophy type I (family F1); lattice corneal dystrophy variants (families F2 and F7). There is a noticeable phenotypic
heterogeneity between corneal morphology of lattice corneal dystrophy variants caring the same H626R mutation. A: Male patient (F1; 37
years). Slit-lamp retroillumination photograph showing diffuse multiple lattice lines. LCDI/R124C mutation. B: Male patient (F1; 37 years).
High-resolution corneal scan – 1310 nm time. domain OCT. There is a diffuse border between the anterior part of increased reflectivity and
normal corneal stroma (arrowheads). The areas of increased stromal reflectivity correspond with corneal opacities. LCDI/R124C mutation.
C: Female patient (F2; 45 years). Slit-lamp photograph. Delicate, fragile, rare lattice lines located centrally. LCD variant/ H626 mutation.
D: Female patient (F2; 45 years). High-resolution corneal scan – 1310 nm time. domain OCT. Opacities with increased reflectivity visible
through the whole depth of the cornea. Some of the opacities are located in the posterior corneal part (arrows). LCD variant/H626 mutation.
E: Female patient (F7; 48 years). Slit-lamp photograph. Thick, distinct lines accompanied by stromal haze extended from limbus to limbus.
LCD variant/H626 mutation. Note the distinct heterogeneity compared to Figure 2C. F: Female patient (F7; 48 years). High-resolution corneal
scan – 1310 nm time. domain OCT. Opacities with increased reflectivity located mainly in the posterior corneal part causing distortion of the
posterior corneal surface. LCD variant/H626 mutation.
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2338exam, a few thin, fragile lattice lines were located centrally in
patients from family F2, while the lines were thick, distinct,
extended  to  limbus  and  accompanied  by  stromal  haze  in
patients from the family F7. OCT scans revealed that corneal
opacities were located deep in the stroma in both families,
even with deformation of the posterior corneal surface in
family F7 (Figure 2C-F). The examination of one corneal
button of family F2 confirmed the deep location of Congo red
positive deposits in the corneal stroma (Figure 3B).
DISCUSSION
The  development  of  molecular  analysis  has  changed  our
understanding of corneal dystrophies. In 1997, Munier et al.
[27]  reported  that  mutation  of  one  gene  (TGFBI)  caused
dystrophies of different corneal layers. Consequently, this
finding rendered classification based on corneal phenotype
archaic, and it was replaced by the new IC3D system in 2008
[1].
Mutational  and  phenotypic  variability  has  previously
been reported, especially in different atypical forms of lattice
Figure 3. Representative images of histopathologic analysis of four corneal sections – three after penetrating keratoplasty and one after deep
anterior lamellar keratoplasty. A: Section of the cornea after deep anterior lamellar keratoplasty. Male patient (F1; 37 years old). Green
birefringence is visible with a polarizing filter (arrowheads). Stromal deposition of amyloid substance in anterior corneal part distorts the
architecture of the corneal lamellae. The absence of Bowman’s layer and thinning of the epithelium are noticeable. LCDI/R124C mutation.
B: Section of the cornea after penetrating keratoplasty. Congo red stain. Female patient (F2; 45 years). Deposits throughout the corneal stroma
stain positive with Congo red. Note the deep, posterior corneal location of the deposit (arrowhead). LCD variant/H626 mutation. C: Section
of the cornea after penetrating keratoplasty. PAS stain. Female patient (F4; 53 years). Note the absence of Bowman’s layer and the distorted
epithelium in correspondence of the granular deposits (arrowheads). There are several granular deposits throughout the corneal stroma (arrows).
GCDI/R555W mutation. D: Section of the cornea after penetrating keratoplasty. PAS stain. Female patient (F4; 53 years). Masson trichrome
stain. Section of the cornea showing the absence of Bowman’s layer and the absence of the epithelium in correspondence with the Masson
trichrome – positive granular deposits (arrows). GCDI/R555W mutation. E: Section of the cornea after penetrating keratoplasty. Masson
trichrome stain. Female patient (F9; 44 years). Note that the granular deposits are placed under the thinner epithelium, thus taking the place
of the former Bowman’s layer. GCDII/R124H mutation. F: Section of the cornea after penetrating keratoplasty. Congo red stain. Female
patient (F9; 44 years). Note the Congo red positive deposits in the anterior corneal stroma. GCDII/R124H mutation.
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2339dystrophy. Recently, the phenotypic heterogeneity was also
described for R124C and R555W mutations [14-20,28,29].
The  most  recent  studies  suggested  greater  genetic
heterogeneity  than  is  currently  known  in  this  group  of
disorders  [20,21,28,29].  This  raises  the  question  whether
classification of the corneal stromal dystrophies should be
based primarily on phenotype or on genotype. To answer that
question,  phenotype-genotype  correlation  reports  from
different ethnic groups, which have been studied widely in
recent years, are needed [2-5,14-20,28-31].
In this first comprehensive report of TGFBI mutations
covering  a  population  in  Poland,  we  found  the  lattice
phenotype was dominant compared to the granular one (41:16
patients;  lattice:granular).  We  identified  five  distinct
mutations  responsible  for  TGFBI  corneal  dystrophies
(R124R, R124H, R555W, R555Q, and H626R). All those
mutations  were  previously  described.  There  was  a  strong
genotype-phenotype  correlation  in  the  case  of  R124R
(families F1, F3, F5, F6, F12, F13, F14, and F15) and R555W
(families F4, F10, and F11) mutations, while there was a
distinct phenotypic heterogeneity in the case of the H626R
mutation  (families  F2  and  F7).  The  mutation  was  first
described by Stewart et al. [32] and Clair-Florent et al. [33] in
1999. Previous authors reported delayed disease onset and
asymmetry of corneal changes [32-36]. The lattice lines were
described as thicker and more distinct than in LCD type 1,
which resembles the phenotype of our family F7. None of the
previous authors revealed such deep deposits location that
they caused the deformation of the posterior corneal surface
as observed on OCT images of affected members from family
F7 (Figure 2F). However, previous reports were based on slit-
lamp and histopathologic findings, while in our study the deep
corneal deposits affecting the posterior corneal surface were
revealed exclusively based on OCT exams, not visible on the
slit-lamp exam.
In our study, the phenotype of Avellino corneal dystrophy
(family F9) differed from the classical form containing both
granular and lattice deposits on the slit-lamp exam. In the case
of family F9, no lattice lines were detectable on the slit-lamp
and  OCT  exams  (Figure  1D-F).  Such  heterogeneity  was
previously reported [37]. In our case, the diagnosis of GCDII
was defined by revealing subepithelial Congo red positive
deposits (Figure 3E,F) and confirming the presence of the
R124H  mutation.  This  underlines  the  need  for  precise
phenotype  analysis  and  TGFBI  screening  for  definite
diagnosis and classification of corneal dystrophies.
The  current  IC3D  classification  system  contains  the
description  of  each  corneal  dystrophy  based  on  slit-lamp,
confocal  microscopy,  histopathology  and  transmission
electron microscopy combined with the results of genetic
analysis. In recent years, reports underlying the role of anterior
segment optical coherence tomography in visualization of
corneal  morphology  in  corneal  dystrophies  have  been
published [38-40]. However, most papers were based on case
reports of a single corneal dystrophy type, and the exam was
performed by one OCT system. We confirmed the utility of
time-domain and spectral OCT systems in establishing the
characteristic  features  and  the  depth  of  corneal  changes.
Analyzing the depth of corneal deposits is one of the most
important factors in choosing a treatment method. Performing
an OCT exam is surely more detailed than the slit-lamp exam
in  assessing  Descemet  membrane  involvement.  OCT
examination  was  already  proven  to  be  useful  in  optical
coherence tomography-guided phototherapeutic keratectomy
or in selection of lamellar versus penetrating keratoplasty as
the  treatment  procedure  of  choice  [41,42].  The  main
advantages of spectral versus time-domain OCT are the ability
to visualize early corneal changes affecting the Bowman’s
layer area (Figure 1) and the possibility of creating three-
dimensional images. Compared to the slit-lamp examination,
OCT  provides  detailed  information  about  the  disease
progression  based  on  documented  analysis  of  corneal
opacities’  depth  and  extent.  Compared  to  confocal
microscopy,  OCT  acquires  less  detailed  information  with
axial resolution to 5 µm, but provides information about the
range of corneal opacities and measures corneal thickness. In
contrast  to  histopathologic  examination,  OCT  can  be
performed in the early stages of the disease, without the need
for keratoplasty. The recent development of OCT shows that
this technique is in continuous change. New OCT prototypes
gain axial resolution of 2–3 µm, which is more than twice that
of OCT devices already used [43]. By using these new OCT
prototypes, we could improve non-contact corneal imaging in
the future.
In  conclusion,  this  study  underlines  the  role  of
comprehensive  phenotype-genotype  analysis  in  TGFBI
corneal dystrophies, describes the TGFBI mutation spectrum
in  a  Polish  population  and  reveals  the  phenotypic
heterogeneity in the case of the H626R mutation.
This  study  also  highlights  the  need  for  a  combined
corneal morphology and genetic assessment to establish the
diagnosis of TGFBI corneal dystrophies.
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